Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is find the highest tolerated dose of paclitaxel
that can be given directly into the liver of patients with advanced cancer involving the
liver. Researchers also want to collect descriptive information on any effects the drug may
have on tumor tissue.